These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1066 related items for PubMed ID: 26105196
1. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII. Khloya P, Ceruso M, Ram S, Supuran CT, Sharma PK. Bioorg Med Chem Lett; 2015 Aug 15; 25(16):3208-12. PubMed ID: 26105196 [Abstract] [Full Text] [Related]
2. 4-Functionalized 1,3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII. SitaRam, Ceruso M, Khloya P, Supuran CT, Sharma PK. Bioorg Med Chem; 2014 Dec 15; 22(24):6945-52. PubMed ID: 25456084 [Abstract] [Full Text] [Related]
3. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Żołnowska B, Sławiński J, Pogorzelska A, Chojnacki J, Vullo D, Supuran CT. Eur J Med Chem; 2014 Jan 15; 71():135-47. PubMed ID: 24291567 [Abstract] [Full Text] [Related]
4. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides. Brzozowski Z, Sławiński J, Saczewski F, Innocenti A, Supuran CT. Eur J Med Chem; 2010 Jun 15; 45(6):2396-404. PubMed ID: 20202722 [Abstract] [Full Text] [Related]
5. 4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII. Khloya P, Celik G, SitaRam, Vullo D, Supuran CT, Sharma PK. Eur J Med Chem; 2014 Apr 09; 76():284-90. PubMed ID: 24589484 [Abstract] [Full Text] [Related]
13. Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII. Angapelly S, Sri Ramya PV, Angeli A, Supuran CT, Arifuddin M. ChemMedChem; 2017 Oct 09; 12(19):1578-1584. PubMed ID: 28940980 [Abstract] [Full Text] [Related]
16. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies. Żołnowska B, Sławiński J, Szafrański K, Angeli A, Supuran CT, Kawiak A, Wieczór M, Zielińska J, Bączek T, Bartoszewska S. Eur J Med Chem; 2018 Jan 01; 143():1931-1941. PubMed ID: 29146134 [Abstract] [Full Text] [Related]
19. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols. Almajan GL, Innocenti A, Puccetti L, Manole G, Barbuceanu S, Saramet I, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2005 May 02; 15(9):2347-52. PubMed ID: 15837323 [Abstract] [Full Text] [Related]
20. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. Puccetti L, Fasolis G, Vullo D, Chohan ZH, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3096-101. PubMed ID: 15908204 [Abstract] [Full Text] [Related] Page: [Next] [New Search]